Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis
- PMID: 17274811
- PMCID: PMC1797014
- DOI: 10.1186/1476-069X-6-4
Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis
Abstract
Background: Exposure to arsenic concentrations in drinking water in excess of 300 microg/L is associated with diseases of the circulatory and respiratory system, several types of cancer, and diabetes; however, little is known about the health consequences of exposure to low-to-moderate levels of arsenic (10-100 microg/L).
Methods: A standardized mortality ratio (SMR) analysis was conducted in a contiguous six county study area of southeastern Michigan to investigate the relationship between moderate arsenic levels and twenty-three selected disease outcomes. Disease outcomes included several types of cancer, diseases of the circulatory and respiratory system, diabetes mellitus, and kidney and liver diseases. Arsenic data were compiled from 9251 well water samples tested by the Michigan Department of Environmental Quality from 1983 through 2002. Michigan Resident Death Files data were amassed for 1979 through 1997 and sex-specific SMR analyses were conducted with indirect adjustment for age and race; 99% confidence intervals (CI) were reported.
Results: The six county study area had a population-weighted mean arsenic concentration of 11.00 microg/L and a population-weighted median of 7.58 microg/L. SMR analyses were conducted for the entire six county study area, for only Genesee County (the most populous and urban county), and for the five counties besides Genesee. Concordance of results across analyses is used to interpret the findings. Elevated mortality rates were observed for both males (M) and females (F) for all diseases of the circulatory system (M SMR, 1.11; CI, 1.09-1.13; F SMR, 1.15; CI, 1.13,-1.17), cerebrovascular diseases (M SMR, 1.19; CI, 1.14-1.25; F SMR, 1.19; CI, 1.15-1.23), diabetes mellitus (M SMR, 1.28; CI, 1.18-1.37; F SMR, 1.27; CI, 1.19-1.35), and kidney diseases (M SMR, 1.28; CI, 1.15-1.42; F SMR, 1.38; CI, 1.25-1.52).
Conclusion: This is some of the first evidence to suggest that exposure to low-to-moderate levels of arsenic in drinking water may be associated with several of the leading causes of mortality, although further epidemiologic studies are required to confirm the results suggested by this ecologic SMR analysis.
Figures
Similar articles
-
[State of health of populations residing in geothermal areas of Tuscany].Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 1):1-104. Epidemiol Prev. 2012. PMID: 23139155 Italian.
-
Drinking water arsenic in Utah: A cohort mortality study.Environ Health Perspect. 1999 May;107(5):359-65. doi: 10.1289/ehp.99107359. Environ Health Perspect. 1999. PMID: 10210691 Free PMC article.
-
Arsenic in public water supplies and cardiovascular mortality in Spain.Environ Res. 2010 Jul;110(5):448-54. doi: 10.1016/j.envres.2009.10.002. Epub 2009 Oct 31. Environ Res. 2010. PMID: 19880104
-
[Studies on markers of exposure and early effect in areas with arsenic pollution: methods and results of the project SEpiAs. Epidemiological studies on population exposed to low-to-moderate arsenic concentration in drinking water].Epidemiol Prev. 2014 May-Aug;38(3-4 Suppl 1):14-24. Epidemiol Prev. 2014. PMID: 25115551 Review. Italian.
-
Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults.Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD012649. doi: 10.1002/14651858.CD012649.pub2. Cochrane Database Syst Rev. 2021. PMID: 34661903 Free PMC article. Review.
Cited by
-
Update of the risk assessment of inorganic arsenic in food.EFSA J. 2024 Jan 18;22(1):e8488. doi: 10.2903/j.efsa.2024.8488. eCollection 2024 Jan. EFSA J. 2024. PMID: 38239496 Free PMC article.
-
Arsenic in Drinking Water and Diabetes.Water (Basel). 2023 May 1;15(9):1751. doi: 10.3390/w15091751. Epub 2023 May 2. Water (Basel). 2023. PMID: 37886432 Free PMC article.
-
Low-to-Moderate Arsenic Exposure and Urothelial Tract Cancers with a Long Latent Period of Follow-Up in an Arseniasis Area.J Epidemiol Glob Health. 2023 Dec;13(4):807-815. doi: 10.1007/s44197-023-00152-x. Epub 2023 Sep 19. J Epidemiol Glob Health. 2023. PMID: 37725327 Free PMC article.
-
Novel cost-effective design for bio-volatilization studies in photosynthetic microalgae exposed to arsenic with emphasis on growth and glutathione modulation.Front Microbiol. 2023 Jun 19;14:1170740. doi: 10.3389/fmicb.2023.1170740. eCollection 2023. Front Microbiol. 2023. PMID: 37405156 Free PMC article.
-
Effects of Inorganic Arsenic on Type 2 Diabetes Mellitus In Vivo: the Roles and Mechanisms of miRNAs.Biol Trace Elem Res. 2024 Jan;202(1):111-121. doi: 10.1007/s12011-023-03669-1. Epub 2023 May 3. Biol Trace Elem Res. 2024. PMID: 37131019
References
-
- NRC . Arsenic in Drinking Water. Washington, DC: National Academy of Sciences Press; 1999.
-
- USEPA National Primary Drinking Water Regulations: Arsenic and clarifications to compliance and new source contaminants monitoring; final rule Fed Reg. 2001. pp. 6976–7066.
-
- Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology. 2000;11:673–679. - PubMed
-
- Guo H-R, Chiang H-S, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and incidence of urinary cancers. Epidemiology. 1997;8:545–550. - PubMed
-
- Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, Smith AH. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology. 1996;7:117–124. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical